Effects of Krill Oil on Intestinal Integrity Markers in Elite Rowers.

Endothelial Dysfunction Clinical Trial

Official title:

Krill Oil Supplementation and Its Effect on Intestinal Permeability Markers in Elite Rowers.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06271434
• Other study ID #: Olej z kryla/jelita
• Status: Not yet recruiting
• Phase: N/A
• Start date: March 23, 2024
• Est. completion date: June 24, 2024

Study information

• Verified date: February 2024
• Source: Poznan University of Physical Education
• Contact: Hanna Dziewiecka, Msc
• Phone: 606880282
• Email: hannadziewiecka[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study aims to check the influence of krill oil on markers of intestinal injury and intoxication.

Research group: the research will be conducted in a homogeneous group of professional rowers (N=30), all competitors qualified for the Polish Youth Rowing Team, aged 18 - 24. The sample size was confiremed in statistical analyses.

Rowing performance test will be conducted at the beginning and at the end of the training camp. Participants will perform a test on a rowing ergometer (Concept II, USA); each subject will have to cover a distance of 2000 m in the shortest possible time which is the distance starting in rowing competitions. The results of both tests will be considered in the selection for the championship team; therefore, athletes will be well motivated to perform both tests with maximum effort.

Hypotesis:

The krill oil will infleunce the gut barier integrity.

Description:

All competitors will be randomly divided into two groups (double-blind):

A. supplemented (n = 15), who will receive one capsule of THYROX (Atlantic krill oil) four times a day.

B. control (n = 15) receiving placebo. The supplementation period will be six weeks.

Characteristic of the supplement:

THYROX (Atlantic krill oil). The daily recommended intake of krill oil is 2000 mg, which includes 350 mg of omega-3 fatty acids, 240 mg of EPA, 110 mg of DHA, 800 mg of phospholipids, and 200 mg of astaxanthin.

Placebo will be produced by MLB Bitrade Sp. z o.o., Poznan.

Measurement: The project contractors will measure all parameters using the available equipment in the ZWKF laboratory in Gorzów Wielkopolski and commercial assay kits.

Polyethylene clotting activator tubes (9 ml) will be centrifuged to separate the morphotic elements from the serum using a centrifuge (3000 rpm for 10 min). The serum will be pipetted into several Eppendorf tubes, then frozen (temp. -80 °C). All the following biochemical parameters will be determined from the extracted serum:

using the ELISA method by the test manufacturer's instructions. The designations include the flowing parameters:

a food diary will be filled day before the study and in the morning before the test, markers of gut injury: I-FABP (intestinal fatty acid binding protein), CLDN-3 (claudin 3) intoxication: LBP (lipopolysaccharide binding protein) stress hormones: ACTH and cortisol will be determined using the colourimetric method on the SPECTROstar Nano reader.

The lactate (La) concentration will be determined from the capillary blood immediately after collection using a commercially available kit (Diaglobal, Germany).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: June 24, 2024
• Est. primary completion date: June 24, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 24 Years

Eligibility

Inclusion Criteria:

• training experience of a minimum of five years,

• minimum training time per week 240 minutes,

• all competitors qualified for the Polish Youth Rowing Team,

• completing a food diary,

• finishing 2000m ergometer test.

Exclusion Criteria:

• Probiotics, prebiotics and antibiotic therapy within the last three months,

• dietary regime,

• gastrointestinal diseases,

• lactose intolerance.

Related Conditions & MeSH terms

• Endothelial Dysfunction

Intervention

Dietary Supplement:
• THYROX (Atlantic krill oil
The daily content of krill oil is 2000 mg, including omega-3 fatty acids 350 mg, EPA - 240 mg, DHA- 110 mg, phospholipids - 800 mg, astaxanthin 200 mg.
• Placebo
The control capsules will be made of olive oil of equal size and color.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Poznan University of Physical Education

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	I-FABP (intestinal fatty acid binding protein)	gut injury (enterocyte)	Blood samples will be taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 3-hour recovery period.
Primary	CLDN-3	gut injury (tight junction)	Blood samples will be taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 3-hour recovery period.
Primary	LBP (lipopolysaccharide binding protein)	endotoxin	Blood samples will be taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 3-hour recovery period.
Primary	Catechyloamines, cortisol	stress hormones	Blood samples will be taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 3-hour recovery period.
Primary	CD14	endotoxin	Blood samples will be taken from the cubital vein at three-time points: before each stress test (after overnight fasting), one minute after the end of the test, and after a 3-hour recovery period.
Secondary	Food intake	macro and micronutrients, fluids	day before the test, morning before the test